Table 1.
Relationships of ASPM and clinicopathological characteristics in 82 patients with lung squamous cell carcinoma (*P < 0.05.)
| Feature | All n=82 | ASPM expression | χ2 | P | |
|---|---|---|---|---|---|
| Low | High | ||||
| n=32 | n=50 | ||||
| Age (year) | 1.333 | 0.248 | |||
| < 55 | 50 | 22 | 28 | ||
| ≥ 55 | 32 | 10 | 22 | ||
| Gender | 0.504 | 0.478 | |||
| Male | 45 | 16 | 29 | ||
| Female | 37 | 16 | 21 | ||
| Smoking | 1.339 | 0.247 | |||
| Yes | 62 | 22 | 40 | ||
| No | 20 | 10 | 10 | ||
| Tumor size | 5.101 | 0.024* | |||
| < 4 cm | 36 | 19 | 17 | ||
| ≥ 4 cm | 46 | 13 | 33 | ||
| Differentiation | 1.718 | 0.190 | |||
| Low | 24 | 12 | 12 | ||
| High | 58 | 20 | 38 | ||
| Clinical stage | 5.316 | 0.021* | |||
| I | 24 | 14 | 10 | ||
| II-III | 58 | 18 | 40 | ||
| Lymphnode metastasis | 0.971 | 0.324 | |||
| Yes | 38 | 17 | 21 | ||
| No | 44 | 15 | 29 | ||